Unknown

Dataset Information

0

Cardiac regenerative capacity is age- and disease-dependent in childhood heart disease.


ABSTRACT: OBJECTIVE:We sought to define the intrinsic stem cell capacity in pediatric heart lesions, and the effects of diagnosis and of age, in order to inform evidence-based use of potential autologous stem cell sources for regenerative medicine therapy. METHODS:Ventricular explants derived from patients with hypoplastic left heart syndrome (HLHS), tetralogy of Fallot (TF), dilated cardiomyopathy (DCM) and ventricular septal defect (VSD) were analyzed following standard in vitro culture conditions, which yielded cardiospheres (C-spheres), indicative of endogenous stem cell capacity. C-sphere counts generated per 5 mm3 tissue explant and the presence of cardiac progenitor cells were correlated to patient age, diagnosis and echocardiographic function. RESULTS:Cardiac explants from patients less than one year of age with TF and DCM robustly generated c-kit- and/or vimentin-positive cardiac mesenchymal cells (CMCs), populating spontaneously forming C-spheres. Beyond one year of age, there was a marked reduction or absence of cardiac explant-derivable cardiac stem cell content in patients with TF, VSD and DCM. Stem cell content in HLHS and DCM strongly correlated to the echocardiographic function in the corresponding ventricular chamber, with better echocardiographic function correlating to a more robust regenerative cellular content. CONCLUSIONS:We conclude that autologous cardiomyogenic potential in pediatric heart lesions is robust during the first year of life and uniformly declines thereafter. Depletion of stem cell content occurs at an earlier age in HLHS with the onset of ventricular failure in a chamber-specific pattern that correlates directly to ventricular dysfunction. These data suggest that regenerative therapies using autologous cellular sources should be implemented in the neonatal period before the potentially rapid onset of single ventricle failure in HLHS or the evolution of biventricular failure in DCM.

SUBMITTER: Traister A 

PROVIDER: S-EPMC6059427 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6064862 | BioStudies
2017-01-01 | S-EPMC5319967 | BioStudies
2015-01-01 | S-EPMC5603726 | BioStudies
2020-01-01 | S-EPMC7393225 | BioStudies
1000-01-01 | S-EPMC4913570 | BioStudies
2014-01-01 | S-EPMC3973710 | BioStudies
1000-01-01 | S-EPMC6138662 | BioStudies
2016-01-01 | S-EPMC4827237 | BioStudies
2020-01-01 | S-EPMC7793240 | BioStudies
2016-01-01 | S-EPMC4860856 | BioStudies